Still on the 8th Oncoclinicas International Symposium, which took place virtually in late 2020, we highlighted three panels dedicated to debating genitourinary neoplasms, focusing on bladder, kidney and prostate cancers. Therapy alternatives for bladder conservation, on invasive muscular illness, the importance of genetic testing in prostate cancer treatment and immunotherapy advances were some of the highlights in the conversation, which also included a live surgery.
A surgical procedure, coordinated by José Milfont, director at Rio de Janeiro Urology Institute – Urotech, was performed live on a 73 years old patient with kidney cell carcinoma on his right kidney. “The challenge was removing the tumor while conserving the kidney, on a hypertensive, diabetic patient”, he commented. The surgeon also reiterates that robotics present invaluable benefits, allowing complex urology surgeries to be performed in a safer, more efficient manner, due to image magnifying, decrease in tremors and minimally invasive procedures.
As for debates on clinical handling of genitourinary neoplasms, oncologist and panel coordinator Carlos Augusto Andrade, from Oncoclinicas – RJ, highlighted the importance of new alternatives for bladder conservation: “An invasive muscular illness treatment is a cystectomy, but we can offer combined treatments of chemotherapy and radiotherapy for patients that do not agree with bladder removal or do not reach clinical requirements for surgery due to comorbidities.”
To read the full article with all research details, access our website. You can also take the opportunity to browse other articles on the 8th Oncoclinicas International Symposium.